Publicado
Evaluation of physicochemical properties and dissolution studies on quality control of low water solubility drugs (raw materials and pharmaceutical formulations)
Evaluación de propiedades fisicoquímicas y estudios de disolución sobre el control de calidad de fármacos de baja solubilidad en agua (materias primas y formulaciones farmacéuticas)
DOI:
https://doi.org/10.15446/rcciquifa.v49n2.89486Palabras clave:
Drugs, low water solubility, physicochemical characterization, dissolution, quality control (en)Drogas, baja solubilidad en agua, caracterización fisicoquímica, disolución, control de calidad (es)
Descargas
The purpose of this study was to evaluate physicochemical properties and dissolution studies of furosemide (FUR), hydrochlorothiazide (HCTZ) and nifedipine (NIF), low water solubility drugs, in raw materials and pharmaceutical formulations. Surface and physicochemical characterization techniques -scanning electronic microscopy (SEM), thermogravimetry (TG), X-ray diffraction (XRD) and infrared (IR) spectrometry- as well as physical and physicochemical tests on tablets and capsules were applied as supporting information on drug quality control. Simple, rapid, and efficient UV-Vis methods were developed and validated for the determination of FUR, HCTZ and NIF samples. SEM exhibited considerable differences in the crystal morphological structures. Among the drugs studied, except for furosemide, more than one polymorph was present in the samples. Drug release profiles were satisfactory for all products. FUR and HCTZ tablets exhibited similar dissolution profiles, with very rapid release to the pharmaceutical specialties (reference, similar and generic). For HCTZ tablets, the similar drug (f2= 48.74) is not equivalent to the reference drug. NIF capsules (reference and compounded) showed a release ≥80% of stated on product labels, in 10 minutes. The results obtained in this study suggest that the quality parameters and drug dissolution profiles may have been influenced by the morphology and size of the crystals, excipients, and technological processes.
El propósito de este estudio fue evaluar las propiedades fisicoquímicas y los estudios de disolución de furosemida (FUR), hidroclorotiazida (HCTZ) y nifedipina (NIF), medicamentos de baja solubilidad en agua, en materias primas y formulaciones farmacéuticas. Técnicas de caracterización fisicoquímica y de superficie: microscopía electrónica de barrido (SEM), termogravimetría (TG), difracción de rayos X (XRD) y espectrometría infrarroja (IR), así como pruebas físicas y fisicoquímicas en tabletas y cápsulas que se aplicaron como información de apoyo sobre el control de calidad. Se desarrollaron y validaron métodos simples, rápidos y eficientes de UV-Vis para la determinación de muestras de FUR, HCTZ y NIF. SEM exhibió diferencias considerables en las estructuras morfológicas de cristal. Entre las drogas estudiadas, a excepción de la furosemida, más de un polimorfo estaba presente en las muestras. Los perfiles de liberación de fármacos fueron satisfactorios para todos los productos. Las tabletas FUR y HCTZ exhibieron perfiles de disolución similares, con una liberación muy rápida a las especialidades farmacéuticas (referencia, similares y genéricas). Para las tabletas de HCTZ, el medicamento similar (f2= 48,74) no es equivalente al medicamento de referencia. Las cápsulas NIF (de referencia y compuestas) mostraron una liberación ≥80% de la indicada en las etiquetas del producto, en 10 minutos. Los resultados obtenidos en este estudio sugieren que los parámetros de calidad y los perfiles de disolución del fármaco pueden haber sido influenciados por la morfología y el tamaño de los cristales, excipientes y procesos tecnológicos.
Referencias
S.S. Anacleto, M.M.C. Borges, H. L. de Oliveira, A. R. Vicente, E. C. de Figueiredo, M.A.L. de Oliveira, B.J.P. Borges, M.A. de Oliveira, W.S. Borges, K.B. Borges, Evaluation of physicochemical properties as supporting information on quality control of raw materials and veterinary pharmaceutical formulations, J. Pharm. Anal., 8, 168-175 (2018).
M. Kesik‐Brodacka, Progress in biopharmaceutical development, Biotechnol. Appl. Biochem., 65, 306-322 (2018).
D. Dahlgren, H. Lennernäs, Intestinal permeability and drug absorption: predictive experimental, computational and in vivo approaches, Pharmaceutics, 11, E411 (2019).
A.F. Santos Júnior, I.S. Barbosa, V.L. Santos, R.L. Silva, E. Caetite Junior, Test of dissolution and comparison of in vitro dissolution profiles of coated ranitidine tablets marketed in Bahia, Brazil, Braz. J. Pharm. Sci., 50, 83-89 (2014).
M.K. Trivedi, K.K. Sethi, P. Panda, S. Jana, A comprehensive physicochemical, thermal, and spectroscopic characterization of zinc (II) chloride using X-ray diffraction, particle size distribution, differential scanning calorimetry, thermogravimetric analysis/differential thermogravimetric analysis, ultraviolet-visible, and Fourier transform-infrared Spectroscopy, Int. J. Pharm. Investig., 7, 33-40 (2017).
R.S. Leite, R.O. Macedo, S.M. Torres, C.C.N. Batista, L.O. Baltazar, S.A. Lima Neto, F.S. Souza, Evaluation of thermal stability and parameters of dissolution of nifedipine crystals, J. Therm. Anal. Calorim., 111, 2117-2123 (2013).
R.C. Silva, F.S. Semaan, C. Novák, E.T.G. Cavalheiro, Thermal behavior of furosemide, J. Therm. Anal. Calorim., 111, 1933-1937 (2013).
M.A. Oliveira, M.I. Yoshida, E.C.L. Gomes, Thermal analysis applied to pharmaceuticals and pharmaceutical formulations in the pharmaceutical industry, Quím. Nova, 34, 1224-1230 (2011).
D. Grooff, M.M. De Villiers, W. Liebenberg, Thermal methods for evaluating polymorphic transitions in nifedipine, Thermochim. Acta, 454, 33-42 (2007).
I. Jendrzejewska, P. Zajdel, E. Pietrasik, Z. Barsova, T. Goryczka, Application of X-ray powder diffraction and differential scanning calorimetry for identification of counterfeit drugs, Monatsh. Chem., 149, 977-985 (2018).
S.C. Jagdale, V.N. Jadhav, A.R. Chabukswar, B.S. Kuchekar, Solubility enhancement, physicochemical characterization and formulation of fast-dissolving tablet of nifedipine-betacyclodextrin complexes, Braz. J. Pharm. Sci., 48, 131-145 (2012).
M. Gallignani, R.A. Rondón, J.F. Ovalles, M.R. Brunetto, Transmission FTIR derivative spectroscopy for estimation of furosemide in raw material and tablet dosage form, Acta Pharm. Sin. B, 4, 376-383 (2014).
C. Sharma, P.N. Badyal, R.K. Rawal, Simultaneous estimation of hydrochlorothiazide, hydralazine hydrochloride, and reserpine using PCA, NAS, and NAS-PCA, Sci. Pharm., 83, 599-610 (2015).
S.K. Dinakaran, B. Alluria, K.R. Annareddy, V.S. Ayyagari, H. Avasarala, R. Kakaraparthy, P.K. Chintamaneni, R. Gadi, Spectrophotometric method development and validation for atorvastatin calcium and nifedipine HCl in bulk and tablet dosage form using absorption ratio method assay of atorvastatin and nifedipine, J. Pharm. Res., 7, 666-669 (2013).
E. Vaculikova, A. Cernikova, D. Placha, M. Pisarcik, P. Peikertova, K. Dedkova, F. Devinsky, J. Jampilek, Preparation of hydrochlorothiazide nanoparticles for solubility enhancement, Molecules, 21, 1005 (2016).
M.H. Shariare, M.A. Altamimi, A.L. Marzan, R. Tabassum, B. Jahan, H.M. Reza, M. Rahman, G.U. Ahsan, M. Kazi, In vitro dissolution and bioavailability study of furosemide nanosuspension prepared using design of experiment (DoE), Saudi Pharm. J., 27, 96-105 (2019).
Y. Tsume, D.M. Mudie, P. Langguth, G.E. Amidon, G.L. Amidon, The biopharmaceutics classification system: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC, Eur. J. Pharm. Sci., 57, 152-163 (2014).
G.L. Amidon, H. Lennernas, V.P. Shah, J.R. Crison, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm. Res., 12, 413-420 (1995).
R. Ghadi, N. Dand, BCS class IV drugs: highly notorious candidates for formulation development, J. Control. Release, 248, 71-95 (2017).
C.C. Chung, Biopharmaceutical innovation system and the influence of policies: the case of Taiwan (2000-2008), Int. J. Health Policy Manag., 1, 125-130 (2013).
J. Cook, W. Addicks, Y.H. Wu, Application of the biopharmaceutical classification system in clinical drug development—an industrial view, AAPS J., 10, 306-310 (2008).
National List of Essential Medicines (RENAME) 2020, Ministry of Health of Brazil, URL: http://portalarquivos2.saude.gov.br/images/pdf/2019/dezembro/24/Rename-2020-final.pdf, accessed December 2019.
Brazilian Health Surveillance Agency (ANVISA), Concepts and definitions of medicines, Ministry of Health of Brazil, URL: http://portal.anvisa.gov.br/medicamentos/conceitos-e-definicoes, accessed December 2019.
C. Barata-Silva, R.A. Hauser-Davis, A.L.O. Silva, J.C. Moreira, Challenges to drug quality control in Brazil, Cad. Saúde Colet., 25, 362-370 (2017).
Brazilian Pharmacopeia, 6rd ed., Brazilian Health Surveillance Agency (ANVISA), Brasília, Brazil, 2019.
M.S. Ferreira, L.C.M.G. Viana, R.A. Matos, R.R. Sá, F.A.S. Silva, M.D. Mota, E.C.L. Cazedey, H.I.F. Magalhães, A.F. Santos Júnior, Comparative in vitro analysis of dissolution profiles of furosemide tablets marketed in Bahia, Brazil, Lat. Am. J. Pharm., 35, 2064-2070 (2016).
L.C.M.G. Viana, M.S. Ferreira, M.D. Mota, H.I.F. Magalhães, A.F. Santos Júnior, Study of dissolution profiles and disintegration of tablets containing hydrochlorothiazide marketed in Bahia, Brazil, Lat. Am. J. Pharm., 34, 2010-2015 (2015).
The United States Pharmacopeia, 41rd ed. (USP 41), United States Pharmacopeial Convention, Rockville, Maryland, USA, 2018.
K.A. Khan, The concept of dissolution efficiency, J. Pharm. Pharmacol., 27, 48-49 (1975).
Brazilian Health Surveillance Agency (ANVISA), Resolution of the Board of Directors - RDC No. 166., Ministry of Health of Brazil, URL: https://www20.anvisa.gov.br/coifa/pdf/rdc166.pdf, accessed December 2019.
International Conference on Harmonization (ICH), Technical Requirements for Registration of Pharmaceuticals for Human Use - Validation of Analytical Procedures: Text and Methodology Q2(R1), URL: https://database.ich.org/sites/default/files/Q2_R1__Guideline.pdf, accessed January 2020.
R.A. Saber, A.K. Attia, W.M. Salem, Thermal analysis study of antihypertensive drugs telmisartan and cilazapril, Adv. Pharm. Bull., 4, 283-287 (2014).
L.C.S. Cides, A.A.S. Araújo, M. Santos-Filho, J.R. Matos, Thermal behaviour, compatibility study and decomposition kinetics of glimepiride under isothermal and non-isothermal conditions, J. Therm. Anal. Calorim., 84, 441-445 (2006).
C.M.P. Souza, J.A.B. Santos, A.L. Nascimento, J.V. Chaves Júnior, F.J.L. Ramos Júnior, S.A. Lima Neto, F.S. Souza, R.O. Macedo, Thermal analysis study of solid dispersions hydrochlorothiazide, J. Therm. Anal. Calorim., 131, 681-689 (2018).
R.O. Macedo, T.G. Nascimento, J.W.E. Veras, Comparison of generic hydrochlorothiazide formulations by means of TG and DSC coupled to a photovisual system, J. Therm. Anal. Calorim., 64, 757-763 (2001).
R.O.C. Filho, P.I.B.M. Franco, E.C. Conceição, M.I.G. Leles, Stability studies on nifedipine tablets using thermogravimetry and differential scanning calorimetry, J. Therm. Anal. Calorim., 97, 343-347 (2009).
K. Egusa, F. Okazaki, J. Schiewe, U. Werthmann, M. Wolkenhauer, Identification of polymorphic forms of active pharmaceutical ingredient in low-concentration dry powder formulations by synchrotron X-Ray powder diffraction, Drugs R D., 17, 413-418 (2017).
S. Shin, J. Kim, Physicochemical characterization of solid dispersion of furosemide with TPGS, Int. J. Pharm., 251, 79-84 (2003).
C. Garnero, A.K. Chattah, M. Longhi, Stability of furosemide polymorphs and the effects of complex formation with β-cyclodextrin and maltodextrin, Carbohyd. Polym., 152, 598-604 (2016).
C. Garnero, A.K. Chattah, M. Longhi, Supramolecular complexes of maltodextrin and furosemide polymorphs: a new approach for delivery systems, Carbohyd. Polym., 94, 292-300 (2013).
M.M. Villiers, J.G. Watt, A.P. Lötter, Kinetic study of the solid-state photolytic degradation of two polymorphic forms of Furosemide, Int. J. Pharm., 88, 275-283 (1992).
Y. Matsuda, E. Tatsumi, Physicochemical characterization of furosemide modifications, Int. J. Pharm., 60, 11-26 (1990).
S.A. El-Gizawy, M.A. Osman, M.F. Arafa, G.M. El Maghraby, Aerosil as a novel co-crystal co-former for improving the dissolution rate of Hydrochlorothiazide, Int. J. Pharm., 478, 773-778 (2015).
J.M. Aceves-Hernández, E. Agacino-Valdés, M. Paz, J. Hinojosa-Torres, Experimental and theoretical study of the conformational analysis of Hydrochlorothiazide, J. Mol. Struct., 786, 1-8 (2006).
N.T. Chinh, N.T.T. Trang, N.V. Giang, D.T.M. Thanh, T.T.X. Hang, N.Q. Tung, C.Q. Truyen, P.M. Quan, P.Q. Long, T. Hoang, In vitro nifedipine release from poly(lactic acid)/chitosan nanoparticles loaded with nifedipine, J. Appl. Polym. Sci., 133, 43330 (2016).
M.E. Brown, B.D. Glass, M.S. Worthington, Binary systems of nifedipine and various cyclodextrins in the solid state. Thermal, FTIR, XRD studies, J. Therm. Anal. Calorim., 68, 631-646 (2002).
M. Gallignani, R.A. Rondón, J.F. Ovalles, M.R. Brunetto, Transmission FTIR derivative spectroscopy for estimation of furosemide in raw material and tablet dosage form, Acta Pharm. Sin. B, 4, 376-383 (2014).
A.A. Bunaciu, H.Y. Aboul-Enein, S. Fleschin, Application of Fourier transform infrared spectrophotometry in pharmaceutical drugs analysis, Appl. Spectrosc. Rev., 45, 206-219 (2010).
C. Doherty, P. York, Fresemide crystal forms; solid state and physicochemical analyses, Int. J. Pharm., 47, 141-155 (1988).
R.N. Sonpal, P.K. Shelat, A.N. Lalwani, Solubility enhancement of hydrochlorothiazide using a novel drug-drug solid dispersion technology, Int. J. Pharm. Sci. Nanotech., 8, 2924-2936 (2015).
R. Razzaq, N.M. Ranjha, Z. Rashid, B. Nasir, Preparation, and evaluation of novel pH-sensitive poly(butyl acrylate-co-itaconic acid) hydrogel microspheres for controlled drug delivery, Adv. Polym. Tech., 37, 21663 (2018).
R.G. Ricarte, T.P. Lodge, M.A. Hillmyer, Detection of pharmaceutical drug crystallites in solid dispersions by transmission electron microscopy, Mol. Pharmaceutics, 12, 983-990 (2015).
A. Mantas, A.T. Mihranyan, Immediate-release nifedipine binary dry powder mixtures with nanocellulose featuring enhanced solubility and dissolution rate, Pharmaceutics, 11, E37 (2019).
M.H. Sadr, H. Nabipour, Preparation and identification of furosemide nanoparticles, J. Basic Appl. Sci. Res., 3, 666-670 (2013).
F. Osei-Yeboah, C.C. Sun, Validation and applications of an expedited tablet friability method, Int. J. Pharm., 484, 146-155 (2015).
S. Paul, C.C. Sun, The suitability of common compressibility equations for characterizing plasticity of diverse powders, Int. J. Pharm., 532, 124-130 (2017).
A. Pignato, C.R. Birnie, Analysis of compounded pharmaceutical products to teach the importance of quality in an applied pharmaceutics laboratory course, Am. J. Pharm. Educ., 78, 61 (2014).
A.D. Rajkumar, G.K. Reynolds, D. Wilson, S. Wren, M.J. Hounslow, A.D. Salman, Investigating the effect of processing parameters on pharmaceutical tablet disintegration using a real-time particle imaging approach, Eur. J. Pharm. Biopharm., 106, 88-96 (2016).
L.A.L. Soares, P.C. Schmidt, G.G. Ortega, P.R. Petrovick, Effect of compression strength and speed on the properties of tablets containing high concentration of dry plant extract, Acta Farm. Bonaerense, 22, 147-154 (2003).
A.C. Lima, D.C. Michelin, M.R.C. Santos, M.O. Paganelli, R.F. Ignácio, M.V. Chaud, Compression force and humidity on hydrochlorothiazide dissolution profile, Acta Farm. Bonaerense, 25, 104-107 (2006).
O. Anand, L.X. Yu, D.P. Conner, B.M. Davit, Dissolution testing for generic drugs: an FDA perspective, AAPS J., 13, 328-335 (2011).
D. Rumel, S.A. Nishioka, A.A.M. Santos, Drug interchangeability: clinical approach and consumer's point of view, Rev. Saude Publica, 40, 921-927 (2006).
J. Menegola, M. Steppe, E.E.S. Schapoval, Dissolution test for citalopram in tablets and comparison of in vitro dissolution profiles, Eur. J. Pharm. Biopharm., 67, 524-530 (2007).
Brazilian Health Surveillance Agency (ANVISA), Resolution of the Board of Directors (RDC) N.° 31, Ministry of Health of Brazil, URL: http://portal.anvisa.gov.br/documents/33880/2568070/res0031_11_08_2010.pdf/5e157d15-d3d5-4bb9-98db-5667e4d9e0c8, accessed December 2019.
K.J. Souza, P.V. Aléssio, A.J.P.S. Gomes, Specific excipient development for prepared nifedipine capsules masterfully: part I, Rev. Cienc. Farm. Básica Apl., 30, 257-261 (2009).
E.K. De Maria, A.J.P.S. Gomes, Nifedipine manipulated or pharmaceutical specialty? In vitro study, Rev. Eletronica Farm., 5, 31-36 (2008).
G.S. Silveira, L.D. Silva, V.C.F. Mosqueira, J. Souza, Biopharmaceutical evaluation of reference, generic, similar and magisterial medicines containing furosemide, one lower solubility and lower permeability drug, Rev. Bras. Farm., 92, 306-313 (2011).
M.A. Lamolha, A.C.P. Rodrigues, B.C. Silva, F.C. Granata, G.S. Podavin, J.C.O. Lima, Evaluation of pharmaceutical equivalence of furosemide 40mg tablets, Rev. Bras. Farm., 93, 17-21 (2012).
F. Mahle, F. Goelzer, J. Adriano, M. Felippe, N. Vier, R.B.G. Carli, T. Rosa, A.G. Couto, R.M. Lucinda-Silva, Evaluation of the tablet dissolution profile of hydrochlorothiazide marketed in Brazil, Rev. Cienc. Farm. Basica Apl., 28, 265-271 (2007).
M.S. Lee, C.L. Huang, S.H. Huang, Y.P. Chen, C.J. Chen, K.C. Wen, A comparative study on the dissolution profiles of commercial hydrochlorothiazide tablets, J. Food Drug. Anal., 10, 18-24 (2002).
Cómo citar
APA
ACM
ACS
ABNT
Chicago
Harvard
IEEE
MLA
Turabian
Vancouver
Descargar cita
Licencia
Derechos de autor 2020 Revista Colombiana de Ciencias Químico-Farmacéuticas
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
El Departamento de Farmacia de la Facultad de Ciencias de la Universidad Nacional de Colombia autoriza la fotocopia de artículos y textos para fines de uso académico o interno de las instituciones citando la fuente. Las ideas emitidas por los autores son responsabilidad expresa de estos y no de la revista.
Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons de Atribución 4.0 aprobada en Colombia. Consulte la normativa en: http://co.creativecommons.org/?page_id=13